Achieve Life Sciences Awarded Grant from the National Institutes of Health (NIH) for the Evaluation of Cytisinicline in Cessation of Nicotine E-cigarette Use

Achieve Life Sciences has been awarded a grant from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) to evaluate the use of cytisinicline as a treatment for cessation of nicotine e-cigarette use.

Original article available here.

2021-07-27T12:56:06-04:00July 22nd, 2021|Blog|

Share This Story, Choose Your Platform!